These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18789058)

  • 1. Molecular biology of botulinum neurotoxin serotype A: a cosmetic perspective.
    Eapen BR
    J Cosmet Dermatol; 2008 Sep; 7(3):221-5. PubMed ID: 18789058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles.
    Blitzer A; Binder WJ
    Facial Plast Surg Clin North Am; 2001 Aug; 9(3):395-404. PubMed ID: 11457703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B; Rzany BJ; Grover R
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced botulinum toxin techniques against wrinkles in the upper face.
    Salti G; Ghersetich I
    Clin Dermatol; 2008; 26(2):182-91. PubMed ID: 18472059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type A botulinum toxin in the upper aspect of the face.
    Hexsel D; Dal'forno T
    Clin Dermatol; 2003; 21(6):488-97. PubMed ID: 14759582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients.
    Rzany B; Dill-Müller D; Grablowitz D; Heckmann M; Caird D;
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S18-25. PubMed ID: 17241409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use.
    Parsa AA; Lye KD; Parsa FD
    Aesthetic Plast Surg; 2007; 31(2):188-91; discussion 192-3. PubMed ID: 17122996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.
    Chang SP; Tsai HH; Chen WY; Lee WR; Chen PL; Tsai TH
    Int J Dermatol; 2008 Dec; 47(12):1287-94. PubMed ID: 19126019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
    Rubin MG; Dover J; Glogau RG; Goldberg DJ; Goldman MP; Schlessinger J
    J Drugs Dermatol; 2009 May; 8(5):439-44. PubMed ID: 19537366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and management of locoregional complications of botulinum A toxin injections in cosmetic treatment].
    Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S146-51. PubMed ID: 19576482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cosmetic treatments and strategies for the upper face.
    Frankel AS; Markarian A
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):31-9, vi. PubMed ID: 17317553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2006 Sep; 25(3):115-21. PubMed ID: 17055389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond Botox.
    Kher U
    Time; 2003 May; 161(20):58-9. PubMed ID: 12776449
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
    Tsai CY; Chiu WC; Liao YH; Tsai CM
    Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin A in the treatment of the wrinkles in the upper third of the face].
    Gassia V
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 3():S175-80. PubMed ID: 18342124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomic considerations for treatment with botulinum toxin.
    Petrus GM; Lewis D; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):1-9, v. PubMed ID: 17317550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies.
    Bowler PJ
    J Cosmet Dermatol; 2008 Sep; 7(3):241-4. PubMed ID: 18789065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin type B--a rapid wrinkle reducer.
    Jacob CI
    Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.